Serum Market Report 2026

The serum market size has grown rapidly in recent years. It will grow from $1.56 billion in 2025 to $1.72 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to growth in academic research funding, expansion of cell culture techniques, rising use of bovine serum in laboratories, increase in diagnostic testing volumes, early growth of biopharmaceutical manufacturing.

The serum market size is expected to see rapid growth in the next few years. It will grow to $2.56 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to surge in vaccine and biologics production, increasing adoption of precision medicine, expansion of cell-based research pipelines, rising demand for high-purity serum grades, growth in global biopharmaceutical capacity. Major trends in the forecast period include rising demand for serum in cell culture media, shift toward serum quality standardization, growing use of heat-inactivated serum products, expansion of serum applications in vaccine development, increased preference for traceable and certified serum sources.

The rising awareness of age-related skin issues is expected to drive the growth of the serum market. Age-related skin concerns, such as wrinkles, facial lines, hyperpigmentation, and loss of firmness, are increasingly recognized by consumers seeking effective skincare solutions. Serums address these conditions by improving skin tone, reducing visible imperfections, hydrating the skin, and promoting a youthful appearance. For instance, in 2023, according to Cancer Australia, approximately 8,257 new cases of melanoma of the skin were diagnosed, accounting for 2.6% of all cancer-related deaths. The growing focus on skin health and prevention of age-related skin conditions is fueling demand for serum products.

Key companies in the serum market are developing advanced technologies to gain a competitive edge, such as ultrasensitive biomarker detection. Ultrasensitive biomarker detection enables the measurement of biomarkers at extremely low concentrations, allowing for earlier disease detection and monitoring. For example, in July 2023, Quanterix, a US-based company specializing in digital biomarker analysis, launched the LucentAD Biomarker Blood Test. This test measures an isoform of phosphorylated tau protein in plasma and is designed to assist physicians in diagnosing Alzheimer’s disease. By using a serum sample, the test enhances diagnostic accuracy and efficiency, supporting improved patient outcomes.

In October 2024, Mankind Pharma Ltd., an India-based pharmaceutical company, acquired BSV Group for an undisclosed amount. This acquisition aims to strengthen Mankind Pharma’s product portfolio, expand its presence in key therapeutic segments, optimize operational synergies, and drive long-term growth in the Indian pharmaceutical market. BSV Group specializes in branded and generic formulations across multiple therapeutic areas.

Major companies operating in the serum market are Merck Group, Thermo Fisher Scientific Inc., Danaher Corp, Corning Incorporated, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Atlas Biologicals Inc., Proliant Health & Biologicals, Seracare Life Sciences Inc., Lampire Biological Labs Inc., Altogen Labs, Innovative Research Inc., Lee Biosolutions Inc., Bovogen Biologicals Pty. Ltd., Caisson Labs Inc., Gemini BioProducts Holding Inc., Valley Biomedical Products & Services Inc., Equitech-Bio Inc., Rocky Mountain Biologicals, PAN-Biotech GmbH, BIOWEST SAS, Moregate Biotech, Tissue Culture Biologicals, Kerafast Inc., Access Biologicals LLC, Animal Technologies Inc., Cell Applications Inc., Cell Sciences Inc.

North America was the largest region in the serum market in 2025. The regions covered in the serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the serum market by increasing costs associated with cross-border trade of bovine-derived raw materials, processing reagents, and cold-chain logistics equipment, leading to pricing pressure and supply variability. segments such as fetal bovine serum and heat-inactivated serum used in cell culture, biopharmaceutical drugs, and vaccine products are most affected, particularly in north america, europe, and asia-pacific regions reliant on imports. however, tariffs have also encouraged local sourcing, regional serum processing facilities, and stronger quality control practices, supporting long-term supply resilience and domestic production capabilities.

The serum market research report is one of a series of new reports that provides serum market statistics, including serum industry global market size, regional shares, competitors with a serum market share, detailed serum market segments, market trends and opportunities, and any further data you may need to thrive in the serum industry. This serum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Serum is the clear, liquid portion of blood that remains after blood cells and clotting proteins have been removed. It is commonly used as a supplement to basal growth media in cell culture applications.

The main types of serum include bovine serum, fetal bovine serum (FBS), and others. Bovine serum is the transparent, yellow fluid obtained from blood after clotting. Serum can be prepared using heat-inactivated or non-heat-inactivated techniques. It finds applications in biological products, research, cell culture, biopharmaceuticals, vaccines, diagnostics, and other areas.

The serum market consists of sales of specialty fetal bovine serum, newborn calf serum, and donor bovine serum. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.